Loading clinical trials...
Loading clinical trials...
The current project aims to improve the well-being of trans and nonbinary (TNB) individuals through an online intervention (Trans Care) targeting the reduction of symptoms of gender dysphoria. The Trans Care intervention will involve the creation of an online intervention comprised of eight modules intended to reduce symptoms of gender dysphoria, increase active coping, and improve the well-being of TNB individuals. Aim 1 is a feasibility and acceptability study of the proposed intervention and will enroll 100 TNB participants to provide feedback to inform a follow-up randomized controlled trial.
The overall purpose of this project is to create a free intervention that can be disseminated widely throughout TNB communities to improve well-being in an easy, accessible way. Development and execution of the Trans Care intervention involves two primary aims: * Aim 1) Feasibility and acceptability analysis (FAA) \[represented by this study record\] * Aim 2) A pilot randomized controlled trial (RCT) of Trans Care's efficacy \[to be registered to a separate study record\] Aim 1 involves qualitative and quantitative feedback regarding the content of the Trans Care intervention modules, impact on TNB participants well-being, and feasibility and acceptability of Trans Care intervention. Results from the FAA study will then be analyzed and presented to our community partners who will help us develop modifications to Trans Care to increase its efficacy and ease of use. Aim 1 Hypotheses: * The investigators expect that qualitative responses from participants in the FAA study overall will reflect that the Trans Care intervention was feasible and helpful. Any proposed changes from participants' qualitative responses will be incorporated into the final Trans Care intervention presented in the RCT. * The investigators expect that participants in the FAA study will endorse high scores three scale assessment of feasibility and acceptability. Aim 1 Endpoints: The primary endpoint of the study is to determine if the Trans Care intervention is feasible and helpful to TNB individuals for improving their coping strategies. This will be determined through qualitative prompts and a quantitative measure of feasibility and acceptability.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
Yes
University of Wisconsin
Madison, Wisconsin, United States
Start Date
May 23, 2024
Primary Completion Date
August 28, 2024
Completion Date
August 28, 2024
Last Updated
September 19, 2024
138
ACTUAL participants
Trans Care Web App
OTHER
Lead Sponsor
University of Wisconsin, Madison
NCT07252687
NCT07147166
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions